Xtant Medical Holdings, Inc.XTNT
Price (close)
$0.38
Market cap
$52.9M
P/E
—
Revenue (TTM)
$109.5M
Net income
-$11.1M
Dividend yield
—
1-year total return
-41.1%
Net margin
-10.2%
Revenue growth
-14.3%
Debt / equity
0.28x
What Xtant Medical Holdings, Inc. does.
Medical Holdings, Inc. is a global medical technology company focused on the design, development, and commercialization of a comprehensive
portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative
procedures. Our products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical,
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $53.3M | $55.3M | $58.0M | $91.3M | $117.3M | $133.9M |
| Net income | -$7.0M | -$4.8M | -$8.5M | $660,000 | -$16.4M | $5.0M |
| Free cash flow | -$2.3M | -$1.7M | -$7.1M | -$11.0M | -$16.0M | $10.2M |
More on XTNT.
- Xtant Medical Holdings, Inc. summary
- Xtant Medical Holdings, Inc. financial statements
- Xtant Medical Holdings, Inc. key metrics
- Xtant Medical Holdings, Inc. health scores and style box
- Xtant Medical Holdings, Inc. earnings
- Xtant Medical Holdings, Inc. dividends
- Xtant Medical Holdings, Inc. valuation
- Xtant Medical Holdings, Inc. ownership and insiders
- Xtant Medical Holdings, Inc. peers
Figures from Xtant Medical Holdings, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.